VBI Vaccines News and Media


VBI Vaccines News and Media

Featured Videos

November 19, 2020

VBI-1901: Interim Phase 2a Data & Clinical Update

Jeff Baxter and David E. Anderson, Ph.D., discuss updated Phase 2a (Part B) data of VBI-1901 in recurrent GBM patients, as presented at SNO 2020.
August 31, 2020

Sci-B-Vac® Late-Breaker Oral Presentation at EASL 2020

Adam Finn, M.D., Ph.D., discusses Data from the Sci-B-Vac® Phase 3 program at EASL.
August 26, 2020

Preclinical Coronavirus Program Data Webcast

VBI discusses preclinical coronavirus program data and selection of clinical candidates with potential as one-dose vaccines.
June 22, 2020

VBI-1901: AACR 2020 Webcast

David E. Anderson, Ph.D., discusses updated Part B data from the VBI's ongoing Phase 1/2a study of VBI-1901.
October 15, 2016

About Hepatitis B

Hepatitis B is a disease of the liver caused by the hepatitis B virus (“HBV”) characterized by inflammation, injury, and even cell death.

News Alerts

Subscribe to Receive VBI Email Alerts

Media Contact

Nicole Anderson
Director, Corporate Communications & Investor Relations
Telephone: (617) 830-3031 x124

Media Kit

Download Media Kit

Recent Press Releases

VBI on Twitter